WHO calls on nations to scale up investments in hepatitis elimination

Fri, Jul 26, 2019
By publisher
2 MIN READ

Health

THE World Health Organisation (WHO) on Friday urged countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease elimination to save lives.

WHO Director-General, Tedros Ghebreyesus’ appeal came ahead of World Hepatitis Day on July 28.

WHO cited its new study, published on Friday in Lancet Global Health, showing the benefits of investing to eliminate the disease?

The study found that investing 6 billion dollars a year in eliminating hepatitis in 67 low- and middle-income countries would avert 4.5 million premature deaths by 2030, and more than 26 million deaths beyond that target date.

For the vast majority of the 325 million people living with hepatitis B and/or C, accessing testing and treatment remains beyond their reach, said WHO.
A total of 58.7 billion dollars is needed to eliminate viral hepatitis as a public health threat in these 67 countries by 2030.

“Today 80 per cent of people living with hepatitis can’t get the services they need to prevent, test for and treat the disease,” said Ghebreyesus.

“On World Hepatitis Day, we call on all countries to integrate services for hepatitis into benefit packages as part of their journey towards universal health coverage.’’

By investing in diagnostic tests and medicines for treating hepatitis B and C now, countries can save lives and reduce costs related to the long-term care of cirrhosis and liver cancer that result from untreated hepatitis, said the WHO.

There are five types of viral hepatitis infections — A, B, C, D and E.

More than 95 per cent of deaths are caused by chronic hepatitis B and C infections, while hepatitis A and E rarely cause life-threatening illnesses.
Hepatitis D is an additional infection occurring in people living with hepatitis B.

WHO said some countries were acting, citing, for example, India’s offer for free testing and treatment for both hepatitis B and C as part of its universal health coverage plan.

It said the Pakistani government had been able to procure hepatitis C curative treatment at similarly low prices.

-NAN

BE

– July 26, 2019 09:15 GMT

Tags:


Why we need to standardise traditional medicines – NNMDA

THE Nigerian Natural Medicine Development Agency (NNMDA) has called for the standardisation of traditional medicines and its teaching in schools....

Read More
Cancer: Early detection, treatment funds key to patient’s survival – Oncologist

A Consultant Radiation and Clinical Oncologist, Dr Temitope Olatunji, has identified early presentation and adequate funds for appropriate treatment as...

Read More
NNMDA to begin documentation of traditional medicine processes in 2025

THE Nigeria Natural Medicine Development Agency (NNMDA) on Tuesday said that, in 2025,  it would improve research of traditional medicine...

Read More